Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment.
Antithyroid drug
Graves’ disease
Hyperthyroidism
Potassium iodide
Journal
Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485
Informations de publication
Date de publication:
29 Aug 2022
29 Aug 2022
Historique:
pubmed:
25
3
2022
medline:
31
8
2022
entrez:
24
3
2022
Statut:
ppublish
Résumé
The effectiveness of potassium iodide (KI) (100 mg/day) was evaluated in 504 untreated patients with Graves' hyperthyroidism (GD). Initial response to KI within 180 days, the effect of additional methylmercaptoimidazole (MMI) or radioactive iodine (RI) in resistant or escaped patients, and long-term prognosis were evaluated. Serum fT
Identifiants
pubmed: 35321988
doi: 10.1507/endocrj.EJ21-0436
doi:
Substances chimiques
Antithyroid Agents
0
Iodides
0
Iodine Radioisotopes
0
Potassium Iodide
1C4QK22F9J
Methimazole
554Z48XN5E
Thyrotropin
9002-71-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM